APA Citatie

Ryu, H., Song, I., Choi, Y., Yun, H., Jo, D., Kim, J. M., . . . Lee, H. J. (2017). ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy. Medicine (Baltimore).

Chicago Style citaat

Ryu, Hyewon, Ik-Chan Song, Yoon-Seok Choi, Hwan-Jung Yun, Deog-Yeon Jo, Jin Man Kim, Young Bok Ko, en Hyo Jin Lee. "ERCC1 Expression Status Predicts the Response and Survival of Patients With Metastatic or Recurrent Cervical Cancer Treated Via Platinum-based Chemotherapy." Medicine (Baltimore) 2017.

MLA citatie

Ryu, Hyewon, et al. "ERCC1 Expression Status Predicts the Response and Survival of Patients With Metastatic or Recurrent Cervical Cancer Treated Via Platinum-based Chemotherapy." Medicine (Baltimore) 2017.